Quantifying epitope presentation using mass spectrometry

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upon the field of antigen processing and presentation.
Original languageEnglish
Pages (from-to)77 - 80
Number of pages4
JournalMolecular Immunology
Volume68
Issue number2 - Part A
DOIs
Publication statusPublished - 2015

Cite this

Croft, Nathan P ; Purcell, Anthony W ; Tscharke, David C. / Quantifying epitope presentation using mass spectrometry. In: Molecular Immunology. 2015 ; Vol. 68, No. 2 - Part A. pp. 77 - 80.
@article{802100ffc92d4218983f8d69ee195b09,
title = "Quantifying epitope presentation using mass spectrometry",
abstract = "Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upon the field of antigen processing and presentation.",
author = "Croft, {Nathan P} and Purcell, {Anthony W} and Tscharke, {David C}",
year = "2015",
doi = "10.1016/j.molimm.2015.06.010",
language = "English",
volume = "68",
pages = "77 -- 80",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier",
number = "2 - Part A",

}

Quantifying epitope presentation using mass spectrometry. / Croft, Nathan P; Purcell, Anthony W; Tscharke, David C.

In: Molecular Immunology, Vol. 68, No. 2 - Part A, 2015, p. 77 - 80.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Quantifying epitope presentation using mass spectrometry

AU - Croft, Nathan P

AU - Purcell, Anthony W

AU - Tscharke, David C

PY - 2015

Y1 - 2015

N2 - Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upon the field of antigen processing and presentation.

AB - Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upon the field of antigen processing and presentation.

UR - http://www.ncbi.nlm.nih.gov/pubmed/26118903

U2 - 10.1016/j.molimm.2015.06.010

DO - 10.1016/j.molimm.2015.06.010

M3 - Article

VL - 68

SP - 77

EP - 80

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 2 - Part A

ER -